Evidence map›Paper›PMID 25431791›Full record

ArticleTheScientificWorldJournal2014

Consequences of lethal-whole-body gamma radiation and possible ameliorative role of melatonin.

Ehsan Mihandoost, Alireza Shirazi, Seied Rabie Mahdavi, Akbar Aliasgharzadeh

Abstract read
In one paragraph

Article in TheScientificWorldJournal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Genome Maintenance Mechanisms at the Chromatin Level.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Article
  6. A derivative of vitamin BScientific reports · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ehsan MihandoostDepartment of Medical Radiation Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Alireza ShiraziDepartment of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Seied Rabie MahdaviDepartment of Medical Physics, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Akbar AliasgharzadehDepartment of Radiology and Medical Physics, Faculty of Paramedicine, Kashan University of Medical Sciences, Kashan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gamma radiation induces the generation of free radicals, leading to serious cellular damages in biological systems. Radioprotectors act as prophylactic agents that are administered to shield normal cells and tissues from the deleterious effects of radiation. Melatonin synergistically acts as an immune-stimulator and antioxidant. We investigated the possible radioprotective role of melatonin (100 mg/kg i.p.) against lethal-whole-body radiation- (10 Gy) induced sickness, body weight loss, and mortality in rats. Results of the present study suggest that exposure to lethal-whole-body radiation incurred mortality, body weight loss, and apoptosis and it also depleted the immunity and the antioxidant status of the rats. Our results show that melatonin pretreatment provides protection against radiation induced mortality, oxidative stress, and immune-suppression. The melatonin pretreated irradiated rats showed less change in body weight as compared to radiation only group. On the other hand, melatonin appeared to have another radioprotective role, suggesting that melatonin may reduce apoptosis through a caspase-3-mediated pathway by blocking caspase-3 activity.

Indexed as

AnimalsAntioxidantsApoptosisBody WeightCaspase 3CatalaseGamma RaysGene ExpressionGlutathione PeroxidaseImmunity, InnateLymphocytesMaleMelatoninOxidative StressRadiation InjuriesRadiation-Protective AgentsAntioxidantsCaspase 3CatalaseGlutathione PeroxidaseMelatoninRadiation-Protective AgentsSuperoxide Dismutase

Identifiers

PMID25431791
PMCPMC4238234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.